Medicine and Health Sciences Commons^™

Use Of A Primary Care Dataset To Describe ‘The Real Picture’ Of Diabetes In Kimberley Aboriginal Communities, Caitlyn S. White, Kimberley Seear, Lorraine Anderson, Emma Griffiths

Journal of the Australian Indigenous HealthInfoNet

Objective
Aboriginal communities are impacted by high rates of diabetes, however these are currently underestimated by national data sources used by policy and decision makers to inform allocation of health resources. We aimed to estimate diabetes prevalence and screening coverage using primary care electronic medical record data.

Methods
A cross-sectional audit was conducted using primary care data from Aboriginal regular Aboriginal Community Controlled Health Service (ACCHS) clinic attendees aged 15 years and over (n=1763) in five remote communities in the Kimberley region. Main outcome measures were overall diabetes prevalence; age-specific diabetes prevalence; prevalence of pre-diabetes; and screening rates among patients …

Physical Health Of People With Mental Illness: A Snapshot Of Consumer Engagement In The Provision Of Care In Primary Care., Irene Ngune, Dianne Wynaden, Karen Heslop

Research outputs 2022 to 2026

Primary care is crucial to the health of people with mental illness. However, there is limited information on their reported engagement in this setting. This study surveyed 100 people with mental illness who had a general practitioner or a general practitioner and a case manager from a tertiary mental health service to determine their engagement level with their GP and what interventions they received to manage their health. Forty-four per cent had their psychotropic medications primarily prescribed by their GP, and 58% reported visiting their GP for physical health problems. Ninety-four point nine percent of participants aged 50 years and …

Blood Eosinophil-Guided Oral Prednisolone For Copd Exacerbations In Primary Care In The Uk (Starr2): A Non-Inferiority, Multicentre, Double-Blind, Placebo-Controlled, Randomised Controlled Trial, Sanjay Ramakrishnan, Helen Jeffers, Beverly Langford-Wiley, Joanne Davies, Samantha J. Thulborn, Mahdi Mahdi, Christine A'Court, Ian Binnian, Stephen Bright, Simon Cartwright, Victoria Glover, Alison Law, Robin Fox, Adam Jones, Christopher Davies, David Copping, Richard E. K. Russell, Mona Bafadhel

Research outputs 2022 to 2026

Background: Systemic glucocorticoids are recommended for use in chronic obstructive pulmonary disease (COPD) exacerbations; however, there is increased harm associated with their use. We hypothesised that the use of eosinophil biomarker-directed oral prednisolone therapy at the time of an exacerbation of COPD was effective at reducing prednisolone use without affecting adverse outcomes. Methods: The studying acute exacerbations and response (STARR2) study was a multicentre, randomised, double-blind, placebo-controlled trial conducted in 14 primary care practices in the UK. We included adults (aged ≥ 40 years), who were current or former smokers (with at least a 10 pack year smoking history) with …